Navigation Links
Team ZERO to Run to End Prostate Cancer in 2009 Marathons

Runners Encouraged to Join ZERO -- The Project to End Prostate Cancer to Take Strides for the Cause

WASHINGTON, April 9 /PRNewswire-USNewswire/ -- Spring is in the air across the country and runners are hitting the pavement to ramp up their running regimes in preparation for upcoming races. ZERO -- The Project to End Prostate Cancer has joined forces with the Bank of America Chicago Marathon and the Marine Corps Marathon to build upon its Team ZERO endurance program and has formed teams to run in both races. If you want to run for a great cause -- ending prostate cancer -- Team ZERO is the team to join in 2009.

ZERO recognizes that maintaining a healthy and active lifestyle helps prevent many diseases, including prostate cancer. Team ZERO is a training program for individuals who wish to participate in races across the country to raise funds for prostate cancer education, screenings and research. This training program matches runners up with the races they'd like to run while helping end prostate cancer. Participating on this team can, in some cases, guarantee you a spot for a competitive run such as a large marathon.

ZERO formed its first team for the 2008 Marine Corps Marathon in Washington, DC on Oct. 26, 2008.

"Running has always been a passion of mine," said Jamie Bearse, COO of ZERO -- The Project to End Prostate Cancer and captain for Team ZERO for the 2008 Marine Corps Marathon. "I'm also passionate about ending prostate cancer which affects one in six American men. The opportunity to run on Team ZERO for my first marathon was the perfect way to combine my passions for a great cause!"

Slots are still available on Team ZERO for both the Bank of America Chicago Marathon on Oct. 11 and the Marine Corps Marathon on Oct. 25. To learn more about Team ZERO and to sign up, visit

About ZERO -- The Project to End Prostate Cancer (

Zero prostate cancer deaths. Zero prostate cancer cases and for those with prostate cancer, it means a zero PSA. Our name conveys what we stand for -- zero tolerance for prostate cancer.

At ZERO, we commit ourselves not only to reduce prostate cancer or alleviate the pain from the disease but to end it. We see a future where all men who have been diagnosed with prostate cancer will be cured or manage their illness with good quality of life, with the support they need to minimize physical and emotional suffering and to cope effectively throughout their cancer journeys.

SOURCE ZERO -- The Project to End Prostate Cancer
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Drug shows activity in men with advanced prostate cancer
2. Stress Management Battles Prostate Cancer Anxiety
3. New Prostate Cancer Drug May Hold Promise
4. Omega-3 EPA/DHA May Decrease Risk of Developing Prostate Cancer
5. A potential new target for treatment of hormone refractory prostate cancer
6. Interviewed Experts Expect Taxotere to Increase Overall Survival More Than Other Drugs, Including Lupron Depot, in Stage III Prostate Cancer
7. Doctors at Henry Ford Health System Treat Ovarian, Prostate, Lung, and Other Forms of Cancer Using Novalis Tx(TM) Platform for Image-Guided Radiosurgery
8. Fox Chase is first cancer center in the nation to use MRI-guided biopsy to detect prostate cancer
9. Free Community Seminar; Reviews Treatment Options for Enlarged Prostate
10. Stanford Study on CyberKnife Radiosurgery for Prostate Cancer Demonstrates 100 Percent PSA Response at 33 months
11. Prostate Cancer Patients in US and Europe Receive Treatments Using Enhanced Seed Prostate Brachytherapy Software
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... of workshops to discuss bioavailability and the need to integrate dose form selection ... in collaboration with OBN, the membership organization supporting and bringing together the UK’s ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... PRMA Plastic ... November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , ... wake up every day excited to rebuild lives and it’s an honor to have ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film Studios brings Final ... ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, ... giving users limitless opportunities to stylize and create designs quickly and easily, all ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of the ... to improve system efficiency and reliability. , The new Q-Suite 6 platform is based ... system avoids locking itself into a specific piece of software for many key components ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
Breaking Medicine Technology: